Trial Profile
A new phase 1 trial of an H5N1 VLP influenza vaccine plus GLA adjuvant
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2013
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary) ; Influenza A virus vaccine-H5N1 (Primary) ; Glycopyranosyl lipid adjuvant; Glycopyranosyl lipid adjuvant
- Indications Influenza A virus H5N1 subtype
- Focus Adverse reactions; Therapeutic Use
- 10 Jan 2013 New trial record